Professor Virendra Rambiritch

Professor Virendra Rambiritch

Person

Professor Virendra Rambiritch

Telephone

+27 (0)31 260 4769

Email

rambiritchv@ukzn.ac.za

Campus

Westville

Research Interests

Diabetes, HIV and TB, and ethics 

Designation

Honorary Senior Research Associate 

 Biosketch

Professor Virendra Rambiritch is a pharmacologist and ethicist with extensive teaching and research experience at the University of KwaZulu-Natal and abroad. He served in senior leadership roles including Director of the former School of Pharmacy and Pharmacology, Head of the Department of Pharmacology, Chair and Deputy Chair of the Bioethics Research Committee, and Chair of the Biosafety Ethics Committee of UKZN.
 
Professor Rambiritch has spent more than three decades in academia. His significant contribution to academic excellence includes being responsible for creating and sustaining both undergraduate and postgraduate pharmacology courses while lecturing medical undergraduate and postgraduate students on ethics and serving as a peer reviewer for the NRF. A passion for teaching, learning and research are the drivers for his continued service to academia and society in large. 
 
Professor Rambiritch has served UKZN and The New England College of Optometry, Boston, with distinction, publishing in prestigious national and international journals such as the Lancet and Neurosurgery. His publication in diverse disciplines including anatomy, pharmacology, dermatology, infectious disease and endocrinology are a testament to his passion for science and his willingness to continue learning.
 
He is currently supervising two PhD students in School of Public Health and has authored a chapter in an edited book.

 
PUBLICATIONS IN BOOKS
 
Rambiritch V, Naidoo P. Chapter 6 , pages 177-192. 2011. Pharmacological Management of Psoriasis. In Psoriasis: causes, diagnosis and treatment. Editor, Julian A Carrasco.  ISBN 978-1-62081-072-9
 
PUBLICTION 2016

Accepted

1.    Rambiritch V. Pillai G, Naidoo P, Maharaj K. Population Pharmacokinetic Modeling of Glibenclamide in Poorly Controlled South African Type 2 Diabetic Subjects. Clinical Pharmacology: Applications and Advances. 2016
 
2.    Naidoo P, Rambiritch V, Wing J. Sitagliptin and Metformin in pre-diabetes (SiMePred): effect of sitagliptin and metformin versus metformin and placebo, on pre diabetes progression to type 2 diabetes: a randomized, double blind, double arm, multicenter clinical trial protocol. JMIR Res Protocol. 2016
Submitted 
3.    Rambiritch V. Pillai G, Naidoo P, Maharaj B. Glibenclamide Population Pharmacokinetic Pharmacodynamic Modeling in South African type 2 diabetic subjects. Clinical Pharmacology: Applications and Advances. 2016
 
In Progress

1.    Naidoo P, Dhedha K, EsmaiL A, Bentely A, Peters, Rambiritch V. Beyond mortality benefits of cell wall lipopolysaccharide lipoarabinomannan (LAM) as point of Care testing in resource limited settings – analysis of data from the LAM multi-country randomized control trial
 
  
PUBLICATION 2014
 
Naidoo P, Rambiritch V, Butkow N and Saman S. 2014. Optimal utilization of sulphonylureas in resource-constrained settings. Cardiovascular Journal of Africa 25(1): 97-99
 
Rambiritch V, Maharaj B and Naidoo P. 2014. Glibenclamide in poorly controlled Type 2 Diabetes: A 12-week, prospective, single-center, open-label, dose-escalation study. Clinical Pharmacology: Advances and Applications 6: 1-7